Vaccines List

Ad26.ZEBOV/MVA-BN Ebola

Ad26.ZEBOV is a monovalent vaccine designed to provide active specific acquired immunity to the Ebola virus.  The vaccine is based on adenovirus type 26 (Ad26) vector expressing the glycoprotein (GP) of... Read more...

Ad5-GUCY2C-PADRE Colon Cancer

Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). GUCY2C, a paracrine hormone receptor producing the... Read more...

Adacel Pertussis

Adacel is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.Read more...

Afluria Influenza

Afluria is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.Read more...

ASP3772 Pneumococcal Disease

 Affinivax's novel vaccine candidate, ASP3772 offers the potential to provide broader protection against pneumococcal disease. 

February 13, 2019, the first subject was dosed with ASP3772, a novel MAPS vaccine targeting Streptococcus... Read more...

Bexsero Meningitis B

Bexsero is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.

It was approved for use starting in 2014.

Bexsero is approved for use in individuals 10 through 25... Read more...

BioThrax Anthrax

AV7909 (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant) is being studied for use as a third-generation anthrax vaccine.

This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a... Read more...

Boostrix

BOOSTRIX is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis.Read more...

BPZE1 Whooping Cough

BPZE1 is a live, attenuated form of the pertussis bacterium. BPZE1 is given as a mist into the nose, rather than a shot in the arm. ILiAD Biotechnologies, LLC (ILiAD) is providing the vaccine.Read more...

CHIKV-VLP Chikungunya

The CHIKV-VLP chikungunya virus vaccine candidate is licensed from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

It received Fast Track designation from the... Read more...

Daptacel Pertussis

DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday).Read more...

Dengvaxia Dengue

Update May 1, 2019: The US Food and Drug Administration (FDA) approved the use of Dengvaxia for children ages 9-16.

Dengvaxia is a live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM... Read more...

Egaten

Egaten is currently the only treatment for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.Read more...

Engerix-B

ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus.Read more...

Flu-v

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza which could be given to a much broader population.Read more...

Fluad

FLUAD is a vaccine that helps protect against the flu.Read more...

Fluarix Quadrivalent

FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Read more...

Flucelvax Quadrivalent Influenza

Flucelvax Quadrivalent (Influenza Vaccine) is the first and only cell culture-based flu vaccine in the United States to help offer protection against 4 flu virus strains for people aged 4 years... Read more...

Flumist Quadrivalent

FluMist Quadrivalent is a vaccine that is sprayed into the nose to help protect against influenza. It can be used in children, adolescents, and adults ages 2 through 49.Read more...

Fluvirin

FLUVIRIN® (Influenza Virus Vaccine) is an inactivated subunit influenza virus vaccine indicated for active immunization of persons aged 4 years and older against influenza disease caused by influenza virus subtypes A and B included in the vaccine.Read more...

Fluzone

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Fluzone High-Dose

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Fluzone Intradermal

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Intradermal Quadrivalent... Read more...

Fluzone Quadrivalent

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.Read more...

Gardasil HPV

Gardasil is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by 4 Human Papillomavirus (HPV) types included in... Read more...

Gardasil 9 HPV

Gardasil®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 45 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV. 

Gardasil 9... Read more...

Harvoni

HARVONI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype (GT) 1, 4, 5 or 6 infection with or without cirrhosis (compensated).Read more...

Havrix Hepatitis A

HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV).Read more...

Hepagam B

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients.Read more...

Heplisav-B Hepatitis B

Heplisav-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

Hepatitis B has a long incubation... Read more...

HydroVax-001 West Nile

HydroVax-001 experimental vaccine was discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University (OHSU) in Portland.Read more...

Imovax

Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies.Read more...

Infanrix

INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age (prior to seventh birthday).Read more...

INO-4500 Lassa Fever

INO-4500 is a DNA-encoded monoclonal antibody (dMAb™) vaccine candidate.

INO-4500 is being clinically tested for the prevention of Lassa Fever.

This vaccine is injected into the muscle or skin with Inovio's proprietary Cellectra... Read more...

INO-A002 Zika

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) vaccine candidate.

INO-A002 is indicated to prevent or treat the Zika virus infection.

The vaccine will be delivered as an intramuscular injection followed by... Read more...

Ixiaro Japanese Encephalitis

Ixiaro is indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV) and is approved for use in individuals 2 months of age and older.Read more...

Kinrix

A single dose of KINRIX is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis.Read more...

M-001

M-001 is a vaccine candidate designed to provide multi-strain and multi-season protection against current and future, seasonal and pandemic influenza.

BiondVax's proprietary technology utilizes a unique combination of conserved and... Read more...

M2SR

FluGen’s M2SR vaccine utilizes a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

M72/AS01E Tuberculosis

M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the GlaxoSmithKline proprietary adjuvant AS01E.

AS01E... Read more...

mAb114 Ebola

mAb114 is a single monoclonal antibody developed by NIAID.Read more...

Menactra

Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...

Menhibrix

MENHIBRIX is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.Read more...

Menveo

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...

MMR II

M-M-R ® II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.

Measles, mumps, and rubella are three common childhood diseases,... Read more...

Mosquirix Malaria

Mosquirix (RTS,S/AS01) is a recombinant vaccine consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.

It is given to children aged 6 weeks to 17 months to help... Read more...

mRNA-1653

mRNA-1653 is designed to protect against human metapneumovirus (hMPV) and parainfluenza type 3 (PIV3), two viruses that cause respiratory infections. Read more...

mRNA-1944 Chikungunya

mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.

It is composed of two... Read more...

MVA-M1+NP Influenza A

Vaccitech’s MVA-M1+NP vaccine candidate aims to prevent a pandemic and seasonal influenza by eliciting broader and more durable immune protection against all “A strains” of the virus, which cannot be achieved by traditional vaccination. Read more...

NanoFlu Influenza

Novavax' NanoFlu is a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine produced in a Sf9 insect cell-baculovirus system.

NanoFlu uses HA protein amino acid sequences that are the same as the recommended wild-type... Read more...

NeoVax

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

Nexvax2 - Celiac Disease

Nexvax2 is being developed to protect celiac disease (CeD) patients who carry the HLA-DQ2.5 immune recognition genes, from inadvertent gluten exposure.Read more...

NIPRAB

NIPRBA, a pre-clinical vaccine candidate, is a novel recombinant vaccine that shows robust immunization against Nipah virus in animal models.  

Using a modified rabies virus vector, and incorporating a gene from... Read more...

PAMVAC

PAMVAC is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

Pediarix

PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis.Read more...

Pedvaxhib

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

PennVax-GP

PENNVAX®-GP is a developmental vaccine to prevent and treat HIV strains primarily present in Africa, Asia, Europe, and North America.Read more...

Pentacel

Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b.Read more...

PF-06482077

PF-06482077 is Pfizer's 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in adults aged 18 years and older.

“While the full extent... Read more...

Pneumovax 23 Pneumococcal Disease

Pneumovax 23 is a vaccine that can help protect against infection by 23 types of pneumococcal bacteria, which are common and often cause serious illnesses.

Pneumococcal disease includes pneumococcal infections... Read more...

Prevnar 13

Prevnar 13® is a vaccine indicated in children 6 weeks through 17 years (prior to the 18th birthday) for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae.Read more...

PRIORIX (MMR-RIT in Clinical Trial)

PRIORIX is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses, separately obtained by propagation either in chick embryo tissue cultures (mumps and measles) or MRC5 human diploid cells (rubella).Read more...

ProQuad

ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.Read more...

PRV-101 (Type 1 Diabetes)

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.Read more...

Quadracel

Quadracel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis. A single dose of Quadracel vaccine is approved for use in children 4 through 6 years of... Read more...

Rabavert

RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups.Read more...

Recombivax HB

RECOMBIVAX HB is indicated for prevention of infection caused by all known subtypes of hepatitis B virus.Read more...

RiVax®

RiVax® is Soligenix’s proprietary vaccine developed to protect against exposure to ricin toxin and is the most advanced vaccine product in the company’s portfolio.Read more...

Rotarix Rotavirus

Rotarix (Rotavirus Vaccine, Live, Oral), for oral administration, is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to G1P[8] type.

This rotavirus strain is propagated on Vero... Read more...

Rotateq Rotavirus

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9.

It is administered as a 3-dose series to infants between the... Read more...

Sabin IPV Polio

Sabin IPV developed by Sinovac Biotech is a liquid trivalent vaccine (0.5 mL/dose) for intramuscular injection. It was generated from Sabin poliovirus type 1, 2, and 3 strains grown on... Read more...

scMAYV-E (Mayaro Virus)

The scMAYV-E DNA vaccine was administered to mice by intramuscular injection followed by pulses of electricity designed to make cells more permeable to foreign DNA and enhance vaccine uptake, which allows for dose-sparing.Read more...

Shingrix Shingles

Shingrix (Zoster Vaccine Recombinant, Adjuvanted) is a recombinant varicella-zoster virus (VZV) glycoprotein E (gE) antigen that is reconstituted at the time of use with AS01B suspension, a proprietary adjuvant containing QS-21... Read more...

Sky Zoster Shingles

Sky Zoster is an inactivated vaccine, consisting of virus particles, bacteria, or other pathogens that have been grown in culture and then killed, reducing infectivity and making it safer than live attenuated vaccines.Read more...

Stamaril Yellow Fever

Sanofi Pasteur confirms that YF-VAX® (Yellow Fever Vaccine) is unavailable to order in the U.S. until mid-2019 as the company transitions production to a new state-of-the-art facility.Read more...

TAK-003 Dengue

TAK-003 is an investigational live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus.

On January 29, 2019, Takeda announced TAK-003 which is in... Read more...

TAK-426 Zika

 TAK-426  (PIZV) is Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.

Takeda’s Zika vaccine candidate is currently being studied in a Phase 1 trial (ZIK-101) which was last updated on March... Read more...

Trumenba

Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B.Read more...

Truvada

TRUVADA for PrEP (pre-exposure prophylaxis) is a prescription medicine that is used together with safer sex practices to help reduce the risk of getting HIV-1 through sex.Read more...

Twinrix

TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.Read more...

TY014 Yellow Fever

TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered... Read more...

Typhim VI

TYPHIM Vi is manufactured by Sanofi Pasteur for intramuscular use for protection against Typhoid Fever.Read more...

UB-311

UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer's disease.Read more...

V114 Pneumococcal Disease

V114 is Merck’s investigational 15-valent pneumococcal conjugate vaccine in Phase 3 development for the prevention of pneumococcal disease in adults and children.

V114 consists of pneumococcal polysaccharides from 15 serotypes... Read more...

V920 Ebola

V920 is a recombinant, replication-competent vaccine, consisting of a vesicular stomatitis virus (VSV), which has been genetically engineered to express a glycoprotein from the Zaire ebolavirus so as to provoke a neutralizing immune response to the Ebola virus.

Merck's V920  (rVSVΔG-ZEBOV-GP) ... Read more...

Vaqta Hepatitis A

VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older.

 Read more...

Varivax

VARIVAX is a vaccine indicated for active immunization for the prevention of varicella (ChickenPox) in individuals 12 months of age or older.Read more...

Varizig

VARIZIG [Varicella Zoster Immune Globulin (Human)] is indicated in the United States for post-exposure prophylaxis of varicella (chickenpox) in high risk patient groups including immunocompromised children, newborns, and pregnant women.Read more...

Vaxchora

Vaxchora is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.Read more...

VGX-3100 HPV

VGX-3100 is an investigational immunotherapy designed to treat pre-cancers and cancers caused by human papillomavirus (HPV).

VGX-3100 includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16... Read more...

Vivotif

Vivotif is an oral vaccine for typhoid fever, a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serotype Typhi (S Typhi).Read more...

VLA15 Lyme Disease

VLA15 is a multivalent vaccine that targets the outer surface protein A (OspA) of Borrelia and is under Fast Track Designation by the Food and Drug Administration (FDA). Read more...

VLA1553 Chikungunya

VLA1553 is a monovalent, single dose, live-attenuated vaccine candidate for protection against chikungunya.

It was granted Fast Track designation by the US Food and Drug Administration (FDA) in December 2018.... Read more...

VPM1002 Tuberculosis

VPM1002 is a formulated, lyophilized cake of live recombinant Mycobacterium bovis rBCGÄureC::Hly+; VPM1002.   

VPM1002 is the active pharmaceutical ingredient. It is a genetically modified BCG vaccine derived from the... Read more...

VXA‑G1.1-NN Norovirus

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

YF-VAX Yellow Fever

YF-VAX is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older.Read more...

Zostavax

ZOSTAVAX is a single shot vaccine for adults 50 years of age or older that helps to boost the immune system against Shingles.Read more...